目的评价分子吸附再循环系统(MARS)治疗慢性肝功能衰竭患者的临床疗效及安全性。
Objective To evaluate the effect and safety of a single treatment using molecular adsorbent recirculating system (MARS) on patients with chronic liver failure.
目的：评价分子吸附再循环系统(MARS)治疗慢性肝功能衰竭的临床疗效及其安全性。
Objective To evaluate the effect of a single treatment and safety using molecular adsorbent recirculating system (MARS) in patients with chronic liver failure.
结论MARS治疗慢性肝功能衰竭具有很好的临床效果和安全性，可作为辅助治疗慢性肝功能衰竭的方法之一。
Conclusion MARS is one of the complementary methods that are safe and effective for patients with chronic liver failure.
急性肝功能衰竭或慢性疾病的进展可能会导致无胆汁粪便。
Acholic feces may occur with acute liver failure or progression of chronic disease.
慢性中度中毒1.17%，表现为重症肝病，均死于肝功能衰竭。
Chronic severe poisoning was found in 1.17% of the patients and all of them died of liver failure.
邓洪，顾琳，赵志新， 张晓红，彭晓谋，高志良探讨慢性乙型肝炎患者拉米夫定耐药后出现肝功能衰竭的危险因素。
To investigate the risk factors of liver failure due to lamivudine resistance in the patients with chronic hepatitis B.
邓洪，顾琳，赵志新， 张晓红，彭晓谋，高志良探讨慢性乙型肝炎患者拉米夫定耐药后出现肝功能衰竭的危险因素。
To investigate the risk factors of liver failure due to lamivudine resistance in the patients with chronic hepatitis B.
应用推荐